Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Synthetic Human Osteopontin peptide (164-179) (QYPDATDEDITSHMES) KLH conjugated|
|Storage buffer||whole serum|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:250|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA1-21421 cross reacts with human osteopontin peptide (164-179). It does not cross react with human osteopontin peptide (75-90), human osteonectin or human bone sialoprotein.
PA1-21421 has been successfully used in ELISA and Immunohistochemistry (Paraffin) procedures.
PA1-21421 immunogen corresponds to synthetic Human Osteopontin peptide (164-179) (QYPDATDEDITSHMES) KLH conjugated.
Osteopontin is the principal phosphorylated glycoprotein of bone and is expressed in a limited number of other tissues including dentine. Osteopontin is produced by osteoblasts under stimulation by calcitriol and binds tightly to hydroxyapatite. It is also involved in the anchoring of osteoclasts to the mineral of bone matrix via the vitronectin receptor, which has specificity for osteopontin.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
early T-lymphocyte activation 1; nephropontin; osteopontin; osteopontin/immunoglobulin alpha 1 heavy chain constant region fusion protein; secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1); SPP1/CALPHA1 fusion; urinary stone protein; uropontin
BNSP; BSPI; ETA-1; OPN; PSEC0156